Camena Bioscience

Developer of a nucleic acid synthesis technology platform

placeCambridge, England, United Kingdom calendar_todayFounded 2016 groups4 employees language camenabio.com

Registered entities

Innovation

9 patent families (3 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 388 times.

YearFilings
20181
20192
20202
20213
20225
20234
20244
20251
20261

Social engagement

Social engagement: 8K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; lead investors include Mercia.

Investor typeCountShare
Other / undisclosed16100%

Recent activity

28 Apr 2026
Expansion
Sidney Sussex Building, Chesterford Research Park
Coming soon